- July 12, 2022
- Comments : 0
NBIF announces a $200,000 follow-on investment in Soricimed to support better cancer outcomes
FREDERICTON – NBIFtoday announced the closing of a $200,000 investment in Moncton-based Soricimed Biopharma, a privately held clinical-stage company focused primarily on the development of targeted, first-in-class cancer treatments. Soricimed was founded in 2005 following the discovery of a unique...